According to the report published by Visiongain, the Artificial Insemination market is estimated at USD 1.95 billion in 2020 and is expected to grow over the forecast period 2020-2030 at a CAGR of 8.7 percent fold. Artificial insemination (AI) is the compulsory positioning of semen in the female reproductive tract by a technique other than artificial mating which is one of a set of techniques frequently recognized as “aided sexual systems” (ART), by which children are produced by enabling gametes (sperm and oocytes) meetings. According to the WHO, infertility affects about 10 percent of females immediately or indirectly. Additionally, National Health Institutes indicated that infertility impacts about 12% of sexual age women.
Rising prevalence of late parenthood
Delayed parenthood is one of the main variables that lead to infertility in the current century and drives request for artificial insemination among families. This has resulted in a negative impact on European nations and some Asian nations. The worldwide average era for the first kid to bear has risen dramatically over the last few centuries. More females in their 30s have kids relative to those in their 20s, according to studies. Factors such as the increasing use of contraceptives, increasing concentrate on higher education and profession, and rising urbanization and shifts in culture have resulted to the increase of first pregnancy in the average era and led to a reduction in fertility rates, thereby necessitating the adoption of procedures such as artificial insemination.
Continuous development in the amount of fertility hospitals in the U.S. and Canada, an rise in women’s drug addiction and tobacco, unprotected sexual intercourse, and a growing rate of scheduled pregnancy support this market growth in America. The European industry is also continually increasing. This industry in Europe is driven by deterioration in reproductive health among females, reduced number of females during pregnancy, enhanced family revenue and request for technological development in artificial insemination. During the forecast period, the Asia-Pacific economy is anticipated to demonstrate the highest development on the Artificial Insemination industry. Increased numbers of miscarriages, absence of knowledge of reproductive health, increased psychological and physical stress contribute to the development of this Asia-Pacific industry. India’s government has a range of women’s programs in agricultural regions. In India, Janani Suraksha Yogana under National Health Mission was a great success initiating women to carry out institution delivery which provided cash assistance to pregnant women after delivery. Middle East and Africa show steady growth in this market.
The cost-effectiveness of artificial insemination devices and continuing studies to improve the efficiency and achievement frequency of pregnancy through artificial insemination are expected to create appealing development possibilities for the worldwide artificial insemination industry. Furthermore, the evolving pattern of late pregnancies among females and the increase in health care expenditure and disposable income have led considerably. Increasing cultural recognition has also performed a major part in the development of the worldwide industry for artificial insemination. The intracervical insemination technique segment is expected to hold the highest market share in global market for artificial insemination through 2030.
Segment Artificial Husband Insemination (AIH) resulted the industry. Witnessing the highest CAGR over the forecast period is also anticipated. Donor insemination (AID) is chosen by women with non-viable sperm as the last option. AID can also be selected by single females or same-sex couples. Donor insemination has proved secure as donor private medical and comprehensive family history is expected to be provided by sperm stores.
Why you should buy Artificial Insemination Market Forecast 2020-2030: Forecasts and Analysis by End Use (Home, Fertility Clinics & Other Facilities), By Type (Intrauterine, Intravaginal), By Source Type (AIH, AID) and Geography, with Profiles of Leading Companies.
What is the future of the Artificial Insemination market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information
– View Artificial Insemination market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Artificial Insemination revenue forecast
– Artificial Insemination connections forecast
– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Artificial Insemination market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Artificial Insemination sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Artificial Insemination industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Artificial Insemination submarkets with individual forecasts and analysis from 2020-2030.
– Type submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– Source submarket forecast 2020-2030
– Learn about the market prospects for the leading Artificial Insemination market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Artificial Insemination revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Type Revenue Forecast 2020-2030
– Intravaginal Market Forecast, 2020-2030
– Intracervical Market Forecast, 2020-2030
– Intrauterine Market Forecast, 2020-2030
– Intratubal Market Forecast, 2020-2030
– Other Type Market Forecast, 2020-2030
– End-Use Revenue Forecast 2020-2030
– Fertility Clinics & Other Facilities Market Forecast, 2020-2030
– Home Market Forecast, 2020-2030
– Other End-Use Market Forecast, 2020-2030
– Source Revenue Forecast 2020-2030
– AIH-Husband Market Forecast, 2020-2030
– AID-Donor Market Forecast, 2020-2030
– Other Source Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Artificial Insemination markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Artificial Insemination companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Artificial Insemination revenue forecast 2020-2030
– US Artificial Insemination revenue forecast 2020-2030
– Canada Artificial Insemination revenue forecast 2020-2030
– Mexico Artificial Insemination revenue forecast 2020-2030
– North America Artificial Insemination by Type revenue forecast 2020-2030
– North America Artificial Insemination by End-Use revenue forecast 2020-2030
– North America Artificial Insemination by Source revenue forecast 2020-2030
– Asia Pacific Artificial Insemination revenue forecast 2020-2030
– China Artificial Insemination revenue forecast 2020-2030
– Japan Artificial Insemination revenue forecast 2020-2030
– India Artificial Insemination revenue forecast 2020-2030
– Australia Artificial Insemination revenue forecast 2020-2030
– Rest of Asia Pacific Artificial Insemination revenue forecast 2020-2030
– Asia Pacific Artificial Insemination by Type revenue forecast 2020-2030
– Asia Pacific Artificial Insemination by End-Use revenue forecast 2020-2030
– Asia Pacific Artificial Insemination by Source revenue forecast 2020-2030
– European Artificial Insemination revenue forecast 2020-2030
– Germany Artificial Insemination revenue forecast 2020-2030
– UK Artificial Insemination revenue forecast 2020-2030
– France Artificial Insemination revenue forecast 2020-2030
– Italy Artificial Insemination revenue forecast 2020-2030
– Spain Artificial Insemination revenue forecast 2020-2030
– Rest of Europe Artificial Insemination revenue forecast 2020-2030
– European Artificial Insemination by Type revenue forecast 2020-2030
– European Artificial Insemination by End-Use revenue forecast 2020-2030
– European Artificial Insemination by Source revenue forecast 2020-2030
– Rest of World Artificial Insemination revenue forecast 2020-2030
– Rest of World Artificial Insemination by Type revenue forecast 2020-2030
– Rest of World Artificial Insemination by End-Use revenue forecast 2020-2030
– Rest of World Artificial Insemination by Source revenue forecast 2020-2030
– Explore the factors affecting Artificial Insemination product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Artificial Insemination industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Artificial Insemination companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Artificial Insemination Market
Hi-Tech Solutions
Pride Angel
Rocket Medical Plc
Kitazato Corporation
Fujifilm Irvine Scientific
Rinovum Women’s Health, Llc
Genea Limited
Vitrolife
Insemination Supplies, LLC
Clearblue
Discover Information found nowhere else in this independent assessment of the Artificial Insemination market
The Artificial Insemination Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By Source and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Insemination sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Artificial Insemination Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By Source and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Artificial Insemination market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Artificial Insemination sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Artificial Insemination Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By Source and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Insemination sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Artificial Insemination Market Definition
1.2 Global Artificial Insemination Market Overview
1.3 Global Artificial Insemination Market Segmentation
1.4 Research Scope of Artificial Insemination in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Artificial Insemination Systems Market
2.1 Market Definition
2.2 Industry Outlook
2.3 Value Chain Analysis
2.4 Industry Structure
2.5 Current Status & Trends
2.6 Demand & Supply Analysis
2.7 Trade Analysis
2.8 Price Trend Analysis
2.9 Various biochemical tests used for asses the sperm fertility
2.9.1 Methylene blue reduction test
2.9.2 Cold shock resistance test
2.9.3 Zone free hamster egg penetration test
2.9.4 Sperm mucus penetration test
2.9.5 Hypo-osmotic swelling test
2.9.7 Computer assisted semen evaluation
2.9.8 Fructolysis index
2.9.9 Oxygen utilization test
2.9.10 Millovanov’s resistance test
2.9.11 Hyaluronidase contents
3. Global Artificial Insemination Market Analysis
3.1 PEST Analysis of the Artificial Insemination Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.4.1 Growing awareness and social acceptance of assisted reproductive technologies
3.4.2 Single women and same-sex couples prefer artificial insemination
3.4.3 Unsupportive government regulations in certain areas
3.4.4 Constant rise in infertility rate
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Artificial Insemination Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Artificial Insemination: Global Market Analysis by Segments
4.1 Global Artificial Insemination Market Forecast, by Type 2020-2030
4.1.1 Type Overview
4.1.2 Intravaginal Market Forecast, 2020-2030
4.1.3 Intracervical Market Forecast, 2020-2030
4.1.4 Intrauterine Market Forecast, 2020-2030
4.1.5 Intratubal Market Forecast, 2020-2030
4.1.6 Other Type Market Forecast, 2020-2030
4.2 Global Artificial Insemination Market Forecast, by End-Use 2020-2030
4.2.1 End-Use Overview
4.2.2 Fertility Clinics & Other Facilities Market Forecast, 2020-2030
4.2.3 Home Market Forecast, 2020-2030
4.2.4 Other End-Use Market Forecast, 2020-2030
4.3 Global Artificial Insemination Market Forecast, by Source 2020-2030
4.3.1 Source Overview
4.3.2 AIH-Husband Market Forecast, 2020-2030
4.3.3 AID-Donor Market Forecast, 2020-2030
4.3.4 Other Source Market Forecast, 2020-2030
5. Leading Regions in Artificial Insemination Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Artificial Insemination Market Forecast, 2020-2030
5.2.1 North America Artificial Insemination Submarket, By Type Forecast 2020-2030
5.2.2 North America Artificial Insemination Submarket, By End-Use Forecast 2020-2030
5.2.3 North America Artificial Insemination Submarket, By Source Forecast 2020-2030
5.2.4 North America Artificial Insemination Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Artificial Insemination Market, Forecast 2020-2030
5.2.4.2 Canada Artificial Insemination Market, Forecast 2020-2030
5.2.4.3 Mexico Artificial Insemination Market, Forecast 2020-2030
5.3 Europe Artificial Insemination Market Forecast, 2020-2030
5.3.1 Europe Artificial Insemination Submarket, By Type Forecast 2020-2030
5.3.2 Europe Artificial Insemination Submarket, By End-Use Forecast 2020-2030
5.3.3 Europe Artificial Insemination Submarket, By Source Forecast 2020-2030
5.3.4 Europe Artificial Insemination Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Artificial Insemination Market, Forecast 2020-2030
5.3.4.2 Germany Artificial Insemination Market, Forecast 2020-2030
5.3.4.3 France Artificial Insemination Market, Forecast 2020-2030
5.3.4.4 Italy Artificial Insemination Market, Forecast 2020-2030
5.3.4.5 Spain Artificial Insemination Market, Forecast 2020-2030
5.3.4.6 The Netherlands Artificial Insemination Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Artificial Insemination Market, Forecast 2020-2030
5.4 Asia-Pacific Artificial Insemination Market Forecast, 2020-2030
5.4.1 Asia-Pacific Artificial Insemination Submarket, By Type Forecast 2020-2030
5.4.2 Asia-Pacific Artificial Insemination Submarket, By End-Use Forecast 2020-2030
5.4.3 Asia-Pacific Artificial Insemination Submarket, By Source Forecast 2020-2030
5.4.4 Asia-Pacific Artificial Insemination Submarket, By Country Forecast 2020-2030
5.4.4.1 China Artificial Insemination Market, Forecast 2020-2030
5.4.4.2 India Artificial Insemination Market, Forecast 2020-2030
5.4.4.3 Japan Artificial Insemination Market, Forecast 2020-2030
5.4.4.4 Korea Artificial Insemination Market, Forecast 2020-2030
5.4.4.5 Indonesia Artificial Insemination Market, Forecast 2020-2030
5.4.4.6 Australia Artificial Insemination Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Artificial Insemination Market, Forecast 2020-2030
5.5 Rest of World Artificial Insemination Market Forecast, 2020-2030
5.5.1 Rest of World Artificial Insemination Submarket, By Type Forecast 2020-2030
5.5.2 Rest of World Artificial Insemination Submarket, By End-Use Forecast 2020-2030
5.5.3 Rest of World Artificial Insemination Submarket, By Source Forecast 2020-2030
6. Leading Companies in The Artificial Insemination Market
6.1 Hi-Tech Solutions
6.1.1 Hi-Tech Solutions Overview
6.1.2 Analysis of Hi-Tech Solutions Products and Services
6.1.3 Hi-Tech Solutions Primary Market Competitors 2019
6.1.4 Hi-Tech Solutions Key Developments
6.2 Pride Angel
6.2.1 Pride Angel Company Overview
6.2.2 Analysis of Pride Angel Products and Services
6.2.3 Pride Angel Primary Market Competitors 2019
6.2.4 Pride Angel Key Developments
6.3 Rocket Medical Plc
6.3.1 Rocket Medical Plc Company Overview
6.3.2 Analysis of Rocket Medical Plc Products and Services
6.3.3 Rocket Medical Plc Primary Market Competitors 2019
6.3.4 Rocket Medical Plc Key Developments
6.4 Kitazato Corporation
6.4.1 Kitazato Corporation Company Overview
6.4.2 Analysis of Kitazato Corporation Products and Services
6.4.3 Kitazato Corporation Primary Market Competitors 2019
6.4.4 Kitazato Corporation Key Developments
6.5 Fujifilm Irvine Scientific
6.5.1 Fujifilm Irvine Scientific Company Overview
6.5.2 Analysis of Fujifilm Irvine Scientific Products and Services
6.5.3 Fujifilm Irvine Scientific Primary Market Competitors 2019
6.5.4 Fujifilm Irvine Scientific Key Developments
6.6 Rinovum Women’s Health, Llc
6.6.1 Rinovum Women’s Health, Llc Company Overview
6.6.2 Analysis of Rinovum Women’s Health, Llc Products and Services
6.6.3 Rinovum Women’s Health, Llc Primary Market Competitors 2019
6.6.4 Rinovum Women’s Health, Llc Key Developments
6.7 Genea Limited
6.7.1 Genea Limited Company Overview
6.7.2 Analysis of Genea Limited Products and Services
6.7.3 Genea Limited Primary Market Competitors 2019
6.7.4 Genea Limited Key Developments
6.8 Vitrolife
6.8.1 Vitrolife Company Overview
6.8.2 Analysis of Vitrolife Products and Services
6.8.3 Vitrolife Primary Market Competitors 2019
6.8.4 Vitrolife Key Developments
6.9 Insemination Supplies, LLC
6.9.1 Insemination Supplies, LLC Company Overview
6.9.2 Analysis of Insemination Supplies, LLC Products and Services
6.9.3 Insemination Supplies, LLC Primary Market Competitors 2019
6.9.4 Insemination Supplies, LLC Key Developments
6.10 Clearblue
6.10.1 Clearblue Company Overview
6.10.2 Analysis of Clearblue Products and Services
6.10.3 Clearblue Primary Market Competitors 2019
6.10.4 Clearblue Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Artificial Insemination Market Segmentation
Figure 2.1 Artificial Insemination Value Chain Analysis
Figure 3.1 Artificial Insemination Supply-Demand Analysis
Figure 4.1 Global Artificial Insemination Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Artificial Insemination Market Forecast 2020-2030
Figure 4.3 Global Artificial Insemination Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Artificial Insemination Market By Type Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Artificial Insemination by Submarket By Type Forecast 2020-2030 ($ million)
Figure 4.20 Global Artificial Insemination Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Artificial Insemination Market, By End-Use Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Artificial Insemination Market, By Source System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Artificial Insemination Market, By Type Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Artificial Insemination Market, By End-Use Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Artificial Insemination Market, by 2020-2030
Figure 5.3 Leading Country/Regional Artificial Insemination Market Share, by 2020
Figure 5.4 Leading Country/Regional Artificial Insemination Market Share, by 2025
Figure 5.5 Leading Country/Regional Artificial Insemination Market Share, by 2030
Figure 5.6 Europe Artificial Insemination Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Artificial Insemination Market, by Forecast 2020-2030
Figure 5.8 Europe Artificial Insemination Submarket, By Type Forecast 2020-2030
Figure 5.9 Europe Artificial Insemination Submarket , By End-Use Forecast 2020-2030
Figure 5.10 Europe Artificial Insemination Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Artificial Insemination Submarket , By Source 2020-2030 ($billion, AGR%)
Figure 5.10 North America Artificial Insemination Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Artificial Insemination Market, by Forecast 2020-2030
Figure 5.12 North America Artificial Insemination Submarket, By Type Forecast 2020-2030
Figure 5.13 North America Artificial Insemination Submarket , By End-Use Forecast 2020-2030
Figure 5.14 North America Artificial Insemination Submarket , By Source Forecast 2020-2030
Figure 5.13 North America Artificial Insemination Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Artificial Insemination Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Artificial Insemination Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Artificial Insemination Submarket, By Type Forecast 2020-2030
Figure 5.17 Asia-Pacific Artificial Insemination Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Artificial Insemination Submarket , By Source Forecast 2020-2030
Figure 5.18 Rest of World Artificial Insemination Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Artificial Insemination Market, by Forecast 2020-2030
Figure 5.20 Rest of World Artificial Insemination Submarket, By Type Forecast 2020-2030
Figure 5.21 Rest of World Artificial Insemination Submarket , By End-Use Forecast 2020-2030
Figure 5.21 Rest of World Artificial Insemination Submarket , By Source Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Pride Angel Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Rocket Medical Plc Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Kitazato Corporation Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Kitazato Corporation Revenue % Share, by Source Segment, 2019
Figure 6.8 Kitazato Corporation Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Kitazato Corporation Revenue % Share, by Business Segment, 2019
Figure 6.10 Fujifilm Irvine Scientific Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Rinovum Women’s Health, Llc Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Genea Limited Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Genea Limited Revenue % Share, by Regional Segment, 2019
Figure 6.14 Vitrolife Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Vitrolife Revenue % Share, by Regional Segment, 2019
Figure 6.16 Vitrolife Revenue % Share, by Business Segment, 2019
Figure 6.17 Insemination Supplies, LLC Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Clearblue Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Clearblue Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Clearblue Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Artificial Insemination Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Artificial Insemination Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Artificial Insemination Submarket, By Source Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Artificial Insemination Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Artificial Insemination Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Artificial Insemination Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Artificial Insemination Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Artificial Insemination Market Submarket, By Source Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Artificial Insemination Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Artificial Insemination Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Artificial Insemination Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Artificial Insemination Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Artificial Insemination Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Artificial Insemination Market Submarket, By Source Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Artificial Insemination Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Artificial Insemination Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Pride Angel Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Pride Angel Products and Services (Product/Service, Segment)
Table 6.8 Pride Angel Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Pride Angel Total Company Recent Development 2015-2019
Table 6.10 Rocket Medical Plc Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Rocket Medical Plc Products and Services (Product/Service, Segment)
Table 6.12 Rocket Medical Plc Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Rocket Medical Plc Total Company Recent Development 2015-2019
Table 6.14 Kitazato Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Kitazato Corporation Products and Services (Product/Service, Segment)
Table 6.16 Kitazato Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Kitazato Corporation Total Company Recent Development 2015-2019
Table 6.18 Fujifilm Irvine Scientific Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Fujifilm Irvine Scientific Products and Services (Product/Service, Segment)
Table 6.20 Fujifilm Irvine Scientific Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Fujifilm Irvine Scientific Total Company Recent Development 2015-2019
Table 6.22 Rinovum Women’s Health, Llc Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Rinovum Women’s Health, Llc Products and Services (Product/Service, Segment)
Table 6.24 Rinovum Women’s Health, Llc Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Rinovum Women’s Health, Llc Total Company Recent Development 2015-2019
Table 6.26 Genea Limited Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Genea Limited Products and Services (Product/Service, Segment)
Table 6.28 Genea Limited Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Genea Limited Total Company Recent Development 2015-2019
Table 6.30 Vitrolife Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Vitrolife Products and Services (Product/Service, Segment)
Table 6.32 Vitrolife Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Vitrolife Total Company Recent Development 2015-2019
Table 6.34 Insemination Supplies, LLC Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Insemination Supplies, LLC Products and Services (Product/Service, Segment)
Table 6.36 Insemination Supplies, LLC Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Insemination Supplies, LLC Total Company Recent Development 2015-2019
Table 6.38 Clearblue Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Clearblue Products and Services (Product/Service, Segment)
Table 6.40 Clearblue Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Clearblue Total Company Recent Development 2015-2019
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
